These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 3548959)
1. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization. Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959 [No Abstract] [Full Text] [Related]
2. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma. Bouillet T; Lepage E; Gisselbrecht C; Boiron M Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study]. Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871 [No Abstract] [Full Text] [Related]
4. Adjuvant FAM2 in resectable gastric cancer. Lise M; Nitti D; Buyse M; Marchet A; Fiorentino M; Dos Santos JG; Duez N Anticancer Res; 1989; 9(4):1017-21. PubMed ID: 2683987 [TBL] [Abstract][Full Text] [Related]
5. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment. Hagin GD; Jain A Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin]. Repetto L; Campora E; Nobile MT; Rosso R G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661 [No Abstract] [Full Text] [Related]
7. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland]. Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442 [TBL] [Abstract][Full Text] [Related]
8. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma. Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959 [TBL] [Abstract][Full Text] [Related]
10. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study. Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837 [No Abstract] [Full Text] [Related]
11. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU. Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma. Rougier P; Droz JP; Theodore C; Piot G; Herait P; Ruffie P; Carde P; Cvitkovic E Cancer Treat Rep; 1987 Dec; 71(12):1301-2. PubMed ID: 3690544 [No Abstract] [Full Text] [Related]
13. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM). Faedi M; Amadori M; Gentilini P; Ridolfi R; Ravaioli A; Amadori D; Biserni R; Bonaguri C Chemioterapia; 1986 Aug; 5(4):240-3. PubMed ID: 3769045 [TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced gastric carcinoma with mitomycin and doxorubicin. Dalley D; Erlichman C; Fine S Cancer Treat Rep; 1986 Jul; 70(7):897-8. PubMed ID: 3719582 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC). De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397 [TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of adenocarcinoma of the stomach]. Zeitoun P; Lirzin P Ann Gastroenterol Hepatol (Paris); 1984; 20(4):213-7. PubMed ID: 6442117 [No Abstract] [Full Text] [Related]
18. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257 [TBL] [Abstract][Full Text] [Related]
20. [FAM as a palliative chemotherapy for gastric cancer with bone metastasis]. Yumoto Y; Okuda T; Shimizu S; Kawase K Gan To Kagaku Ryoho; 1996 Jan; 23(1):107-10. PubMed ID: 8546459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]